| r&d systems 产品目录--泽浩公司 |
| r&d systems 产品目录列表 page 2 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 1135-ra-050 |
recombinant mouse rae-1 epsilon/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1136-ra-050 |
recombinant mouse rae-1 gamma/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1137-sl-050 |
recombinant human siglec-3/cd33/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1138-sl-050 |
recombinant human siglec-7/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1139-sl-050 |
recombinant human siglec-9/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 113-bp-100 |
recombinant human bmp-3 (100 ug) |
100 ug |
r&d systems |
| 113-bp-100/cf |
recombinant human bmp-3, cf (100 ug) |
100 ug |
r&d systems |
| 1141-pi-010 |
recombinant mouse hai-1, cf (10 ug) |
10 ug |
r&d systems |
| 11450-1 |
recombinant human ifn-kappa, cf |
50 µg |
r&d systems |
| 1145-rg-050 |
recombinant human rage/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1146-s6-025 |
recombinant human semaphorin 6a/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1150-ml-020 |
recombinant mouse il-2 (cys 141 ser) (20 ug) |
20 ug |
r&d systems |
| 1150-ml-020/cf |
recombinant mouse il-2 (cys 141 ser), cf (20 ug) |
20 ug |
r&d systems |
| 1151-cl-025 |
recombinant human clf-1/clc complex (25 ug) |
25 ug |
r&d systems |
| 1151-cl-025/cf |
recombinant human clf-1/clc complex, cf (25 ug) |
25 ug |
r&d systems |
| 1152-ga-050 |
recombinant human galectin-1 (50 ug) |
50 ug |
r&d systems |
| 1152-ga-050/cf |
recombinant human galectin-1, cf (50 ug) |
50 ug |
r&d systems |
| 1153-ga-050 |
recombinant human galectin-2 (50 ug) |
50 ug |
r&d systems |
| 1153-ga-050/cf |
recombinant human galectin-2, cf (50 ug) |
50 ug |
r&d systems |
| 1154-ga-050 |
recombinant human galectin-3 (50 ug) |
50 ug |
r&d systems |
| 1154-ga-050/cf |
recombinant human galectin-3, cf (50 ug) |
50 ug |
r&d systems |
| 1155-h6-050 |
recombinant mouse h60/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1156-ng-100 |
recombinant mouse beta-ngf (100 ug) |
100 ug |
r&d systems |
| 1156-ng-100/cf |
recombinant mouse beta-ngf, cf (100 ug) |
100 ug |
r&d systems |
| 1157-nr-050 |
recombinant mouse ngf r/tnfrsf16/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1158-ra-050 |
recombinant mouse rae-1 alpha/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1159-sb-025 |
recombinant human pdgf-dd (25 ug) |
25 ug |
r&d systems |
| 1159-sb-025/cf |
recombinant human pdgf-dd, cf (25 ug) |
25 ug |
r&d systems |
| 1160-a1-050 |
recombinant human bcl-2 related protein a1 (aa 1-152), cf (50 ug) |
50 ug |
r&d systems |
| 1161-lv-100 |
recombinant human livin alpha/kiap, cf (100 ug) |
100 ug |
r&d systems |
| 1162-br-050 |
recombinant human baff r/tnfrsf13c/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1163-cl-025 |
recombinant mouse cd40 ligand/tnfsf5 (25 ug) |
25 ug |
r&d systems |
| 1163-cl-025/cf |
recombinant mouse cd40 ligand/tnfsf5, cf (25 ug) |
25 ug |
r&d systems |
| 1164-cx-025 |
recombinant human cxcl16 (histidine-tagged) (25 ug) |
25 ug |
r&d systems |
| 1164-cx-025/cf |
recombinant human cxcl16 (histidine-tagged), cf (25 ug) |
25 ug |
r&d systems |
| 1165-cx-025 |
recombinant mouse cxcl16 (histidine-tagged) (25 ug) |
25 ug |
r&d systems |
| 1165-cx-025/cf |
recombinant mouse cxcl16 (histidine-tagged), cf (25 ug) |
25 ug |
r&d systems |
| 1166-ng-025 |
recombinant mouse netrin-g1a (25 ug) |
25 ug |
r&d systems |
| 1166-ng-025/cf |
recombinant mouse netrin-g1a, cf (25 ug) |
25 ug |
r&d systems |
| 1167-pr-050 |
recombinant human prolactin r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1168-cr-050 |
recombinant human ret (histidine-tagged) (50 ug) |
50 ug |
r&d systems |
| 1168-cr-050/cf |
recombinant human ret (histidine-tagged), cf (50 ug) |
50 ug |
r&d systems |
| 1169-fr-025 |
recombinant mouse sfrp-2 (25 ug) |
25 ug |
r&d systems |
| 1169-fr-025/cf |
recombinant mouse sfrp-2, cf (25 ug) |
25 ug |
r&d systems |
| 1172-al-050 |
recombinant mouse alcam/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1173-m5-050 |
recombinant mouse icam-5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1176-ir-050 |
recombinant human il-20 r alpha/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1179-rg-050 |
recombinant mouse rage/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 117-vl-025 |
recombinant viral hcmv il-10 (25 ug) |
25 ug |
r&d systems |
| 117-vl-025/cf |
recombinant viral hcmv il-10, cf (25 ug) |
25 ug |
r&d systems |
| 1180-se-010 |
recombinant human dppiv/cd26, cf (10 ug) |
10 ug |
r&d systems |
| 1182-zn-010 |
recombinant human neprilysin, cf (10 ug) |
10 ug |
r&d systems |
| 1183-cy-010 |
recombinant human cathepsin s, cf (10 ug) |
10 ug |
r&d systems |
| 1184-pi-050 |
recombinant human fetuin a/ahsg, cf (50 ug) |
50 ug |
r&d systems |
| 1187-tr-025 |
recombinant mouse trem-1/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1189-j3-050 |
recombinant human jam-c/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 118-ap-100 |
recombinant human il-18 r beta/il-1 r7/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1190-nt-050 |
recombinant rat notch-2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1195-ep-025 |
recombinant human epiregulin (25 ug) |
25 ug |
r&d systems |
| 1195-ep-025/cf |
recombinant human epiregulin, cf (25 ug) |
25 ug |
r&d systems |
| 1196-pi-010 |
recombinant human cystatin c, cf (10 ug) |
10 ug |
r&d systems |
| 11976-1 |
thymosin alpha 1, cf |
500 µg |
r&d systems |
| 1197-ga-050 |
recombinant mouse galectin-3 (50 ug) |
50 ug |
r&d systems |
| 1197-ga-050/cf |
recombinant mouse galectin-3, cf (50 ug) |
50 ug |
r&d systems |
| 1198-ra-050 |
recombinant mouse rae-1 beta/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1199-tw-050 |
recombinant human tweak r/tnfrsf12/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 119-bp-100 |
recombinant human il-18 bpa/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1200-se-010 |
recombinant mouse hgf activator, cf (10 ug) |
10 ug |
r&d systems |
| 1201-pi-010 |
recombinant human cystatin sa, cf (10 ug) |
10 ug |
r&d systems |
| 1202-pi-010 |
recombinant human cystatin d, cf (10 ug) |
10 ug |
r&d systems |
| 1204-ml-025 |
recombinant mouse il-20 (25 ug) |
25 ug |
r&d systems |
| 1204-ml-025/cf |
recombinant mouse il-20, cf (25 ug) |
25 ug |
r&d systems |
| 1206-f3-025 |
recombinant human fgf-3 (25 ug) |
25 ug |
r&d systems |
| 1206-f3-025/cf |
recombinant human fgf-3, cf (25 ug) |
25 ug |
r&d systems |
| 1207-br-050 |
recombinant human il-17b r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1208-ng-050 |
recombinant human nogo receptor/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1209-ev-025 |
recombinant human eg-vegf/pk1 (25 ug) |
25 ug |
r&d systems |
| 1209-ev-025/cf |
recombinant human eg-vegf/pk1, cf (25 ug) |
25 ug |
r&d systems |
| 120-hd-001 |
human pdgf, cf (1 ug) |
1 ug |
r&d systems |
| 120-hd-005 |
human pdgf, cf (5 ug) |
5 ug |
r&d systems |
| 12105-1 |
recombinant mouse ifn-alpha 1 |
100000 u |
r&d systems |
| 1210-gr-050 |
recombinant human growth hormone r (ghr)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 12110-1 |
recombinant mouse ifn-alpha 4 |
100000 u |
r&d systems |
| 1211-gr-050 |
recombinant rat growth hormone r (ghr)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 12125-1 |
recombinant mouse ifn-alpha 11 |
100000 u |
r&d systems |
| 1212-fg-025 |
recombinant human fgf-16 (25 ug) |
25 ug |
r&d systems |
| 1212-fg-025/cf |
recombinant human fgf-16, cf (25 ug) |
25 ug |
r&d systems |
| 12130-1 |
recombinant mouse ifn-alpha 13 |
100000 u |
r&d systems |
| 1213-j3-050 |
recombinant mouse jam-c/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1214-b7-050 |
recombinant rat b7-1/cd80/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1215-cd-050 |
recombinant mouse cd40/tnfrsf5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1220-pg-025 |
recombinant human aggrecan g1-igd-g2 domains, cf (25 ug) |
25 ug |
r&d systems |
| 1224-pl-100 |
recombinant human pd-l2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1227-ga-050 |
recombinant human galectin-4 (50 ug) |
50 ug |
r&d systems |
| 1227-ga-050/cf |
recombinant human galectin-4, cf (50 ug) |
50 ug |
r&d systems |
| 122-bp-100 |
recombinant mouse il-18bpd/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1234-il-025 |
recombinant human il-17c (25 ug) |
25 ug |
r&d systems |
| 1234-il-025/cf |
recombinant human il-17c, cf (25 ug) |
25 ug |
r&d systems |
| 1236-ox-025 |
recombinant mouse ox40 ligand/tnfsf4 (25 ug) |
25 ug |
r&d systems |
| 1236-ox-025/cf |
recombinant mouse ox40 ligand/tnfsf4, cf (25 ug) |
25 ug |
r&d systems |
| 1237-tw-025 |
recombinant mouse tweak/tnfsf12 (25 ug) |
25 ug |
r&d systems |
| 1237-tw-025/cf |
recombinant mouse tweak/tnfsf12, cf (25 ug) |
25 ug |
r&d systems |
| 1238-pi-010 |
recombinant mouse cystatin c, cf (10 ug) |
10 ug |
r&d systems |
| 1239-pi-010 |
recombinant mouse serpin f2/alpha 2-antiplasmin, cf (10 ug) |
10 ug |
r&d systems |
| 123-fe-050 |
recombinant human cd23/fc epsilon rii, cf (50 ug) |
50 ug |
r&d systems |
| 1245-ga-050 |
recombinant mouse galectin-1 (50 ug) |
50 ug |
r&d systems |
| 1245-ga-050/cf |
recombinant mouse galectin-1, cf (50 ug) |
50 ug |
r&d systems |
| 1246-4l-025 |
recombinant mouse 4-1bb ligand/tnfsf9 (25 ug) |
25 ug |
r&d systems |
| 1246-4l-025/cf |
recombinant mouse 4-1bb ligand/tnfsf9, cf (25 ug) |
25 ug |
r&d systems |
| 1247-zv-010 |
recombinant zebrafish vegf 165 (10 ug) |
10 ug |
r&d systems |
| 1247-zv-010/cf |
recombinant zebrafish vegf 165, cf (10 ug) |
10 ug |
r&d systems |
| 1248-ib-025 |
recombinant human il-17b (25 ug) |
25 ug |
r&d systems |
| 1248-ib-025/cf |
recombinant human il-17b, cf (25 ug) |
25 ug |
r&d systems |
| 1250-s3-025 |
recombinant human semaphorin 3a/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1254-n4-025 |
recombinant human netrin-4 (25 ug) |
25 ug |
r&d systems |
| 1254-n4-025/cf |
recombinant human netrin-4, cf (25 ug) |
25 ug |
r&d systems |
| 1255-f3-025 |
recombinant mouse flrg (25 ug) |
25 ug |
r&d systems |
| 1255-f3-025/cf |
recombinant mouse flrg, cf (25 ug) |
25 ug |
r&d systems |
| 1256-ox-050 |
recombinant mouse ox40/tnfrsf4/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1257-fc-050 |
recombinant human fc gamma ria/cd64, cf (50 ug) |
50 ug |
r&d systems |
| 1258-il-025 |
recombinant human il-17e (25 ug) |
25 ug |
r&d systems |
| 1258-il-025/cf |
recombinant human il-17e, cf (25 ug) |
25 ug |
r&d systems |
| 125-pd-005 |
porcine pdgf, cf (5 ug) |
5 ug |
r&d systems |
| 1264-fr-050 |
recombinant human fgf r3 (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1265-pi-010 |
recombinant mouse serpin d1/heparin cofactor ii, cf (10 ug) |
10 ug |
r&d systems |
| 1266-pi-010 |
recombinant human serpin a5, cf (10 ug) |
10 ug |
r&d systems |
| 1267-pi-010 |
recombinant human serpin c1/antithrombin-iii, cf (10 ug) |
10 ug |
r&d systems |
| 1268-pi-010 |
recombinant human serpin a1, cf (10 ug) |
10 ug |
r&d systems |
| 1269-dk-010 |
recombinant human dkk-4 (10 ug) |
10 ug |
r&d systems |
| 1269-dk-010/cf |
recombinant human dkk-4, cf (10 ug) |
10 ug |
r&d systems |
| 126-fl-010 |
recombinant human fas ligand/tnfsf6 (10 ug) |
10 ug |
r&d systems |
| 126-fl-010/cf |
recombinant human fas ligand/tnfsf6, cf (10 ug) |
10 ug |
r&d systems |
| 1274-pi-100 |
recombinant human slpi, cf (100 ug) |
100 ug |
r&d systems |
| 1275-il-025 |
recombinant human il-1f5/fil1 delta (25 ug) |
25 ug |
r&d systems |
| 1275-il-025/cf |
recombinant human il-1f5/fil1 delta, cf (25 ug) |
25 ug |
r&d systems |
| 1278-tr-050 |
recombinant human trem-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 127-n2-025 |
recombinant chicken netrin-2 (25 ug) |
25 ug |
r&d systems |
| 127-n2-025/cf |
recombinant chicken netrin-2, cf (25 ug) |
25 ug |
r&d systems |
| 1280-er-050 |
recombinant mouse egf r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1284-pi-010 |
recombinant mouse cystatin e/m, cf (10 ug) |
10 ug |
r&d systems |
| 1285-pi-010 |
recombinant human cystatin sn, cf (10 ug) |
10 ug |
r&d systems |
| 1286-pi-010 |
recombinant human cystatin e/m, cf (10 ug) |
10 ug |
r&d systems |
| 1287-pi-010 |
recombinant mouse serpin c1/antithrombin-iii, cf (10 ug) |
10 ug |
r&d systems |
| 1288-f3-025 |
recombinant human flrg (25 ug) |
25 ug |
r&d systems |
| 1288-f3-025/cf |
recombinant human flrg, cf (25 ug) |
25 ug |
r&d systems |
| 128-n1-025 |
recombinant chicken netrin-1 (25 ug) |
25 ug |
r&d systems |
| 128-n1-025/cf |
recombinant chicken netrin-1, cf (25 ug) |
25 ug |
r&d systems |
| 1290-il-010 |
recombinant human il-23 (10 ug) |
10 ug |
r&d systems |
| 1290-il-010/cf |
recombinant human il-23, cf (10 ug) |
10 ug |
r&d systems |
| 1294-as-010 |
recombinant human cathepsin e, cf (10 ug) |
10 ug |
r&d systems |
| 1295-pi-010 |
recombinant human serpin a3, cf (10 ug) |
10 ug |
r&d systems |
| 1296-pi-010 |
recombinant human cystatin s, cf (10 ug) |
10 ug |
r&d systems |
| 1297-ne-025 |
recombinant human neurturin (25 ug) |
25 ug |
r&d systems |
| 1297-ne-025/cf |
recombinant human neurturin, cf (25 ug) |
25 ug |
r&d systems |
| 1298-ul-050 |
recombinant human ulbp-2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1299-nk-050 |
recombinant human nkg2d/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1300-ma-050 |
recombinant human mica/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1304-ga-050 |
recombinant mouse galectin-7 (50 ug) |
50 ug |
r&d systems |
| 1304-ga-050/cf |
recombinant mouse galectin-7, cf (50 ug) |
50 ug |
r&d systems |
| 1305-ga-050 |
recombinant human galectin-8 (50 ug) |
50 ug |
r&d systems |
| 1305-ga-050/cf |
recombinant human galectin-8, cf (50 ug) |
50 ug |
r&d systems |
| 1306-re-010 |
recombinant rat erythropoietin (10 ug) |
10 ug |
r&d systems |
| 1306-re-010/cf |
recombinant rat erythropoietin, cf (10 ug) |
10 ug |
r&d systems |
| 1307-fz-050 |
recombinant mouse frizzled-2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1308-nt-050 |
recombinant mouse notch-3/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1309-pr-050 |
recombinant mouse prolactin r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 130-md-050 |
recombinant mouse md-1 (50 ug) |
50 ug |
r&d systems |
| 130-md-050/cf |
recombinant mouse md-1, cf (50 ug) |
50 ug |
r&d systems |
| 1310-se-010 |
recombinant human u-plasminogen activator/urokinase, cf (10 ug) |
10 ug |
r&d systems |
| 1314-sh-025 |
recombinant human sonic hedgehog, n-terminus (shh-n) (25 ug) |
25 ug |
r&d systems |
| 1314-sh-025/cf |
recombinant human sonic hedgehog, n-terminus (shh-n), cf (25 ug) |
25 ug |
r&d systems |
| 1315-nd-025 |
recombinant mouse nodal (25 ug) |
25 ug |
r&d systems |
| 1315-nd-025/cf |
recombinant mouse nodal, cf (25 ug) |
25 ug |
r&d systems |
| 1316-rl-010 |
recombinant rat il-22 (10 ug) |
10 ug |
r&d systems |
| 1316-rl-010/cf |
recombinant rat il-22, cf (10 ug) |
10 ug |
r&d systems |
| 1317-tr-050 |
recombinant mouse thrombopoietin r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1318-rl-010 |
recombinant rhesus macaque il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
| 1318-rl-010/cf |
recombinant rhesus macaque il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
| 1319-tl-010 |
recombinant human tl1a/tnfsf15 (10 ug) |
10 ug |
r&d systems |
| 1319-tl-010/cf |
recombinant human tl1a/tnfsf15, cf (10 ug) |
10 ug |
r&d systems |
| 131-m1-025 |
recombinant human ccl23/mpif-1 (aa 46-120) (25 ug) |
25 ug |
r&d systems |
| 131-m1-025/cf |
recombinant human ccl23/mpif-1 (aa 46-120), cf (25 ug) |
25 ug |
r&d systems |
| 1320-en-025 |
recombinant mouse endoglin/cd105/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1324-wn-002 |
recombinant mouse wnt-3a (2 ug) |
2 ug |
r&d systems |
| 1325-bl-050 |
recombinant human bim (long form), cf (50 ug) |
50 ug |
r&d systems |
| 1328-pi-050 |
recombinant e. coli ecotin, cf (50 ug) |
50 ug |
r&d systems |
| 132-fa-025 |
bovine fgf acidic (25 ug) |
25 ug |
r&d systems |
| 132-fa-025/cf |
bovine fgf acidic, cf (25 ug) |
25 ug |
r&d systems |
| 1330-cd-050 |
recombinant human fc gamma riia/cd32a (50 ug) |
50 ug |
r&d systems |
| 1330-cd-050/cf |
recombinant human fc gamma riia/cd32a, cf (50 ug) |
50 ug |
r&d systems |
| 1334-b7-025 |
recombinant human igfbp-rp1/igfbp-7, cf (25 ug) |
25 ug |
r&d systems |
| 1335-il-025 |
recombinant human il-17f (25 ug) |
25 ug |
r&d systems |
| 1335-il-025/cf |
recombinant human il-17f, cf (25 ug) |
25 ug |
r&d systems |
| 1335-ins-025 |
recombinant human il-17f (nso-expressed) (25 ug) |
25 ug |
r&d systems |
| 1335-ins-025/cf |
recombinant human il-17f (nso-expressed), cf (25 ug) |
25 ug |
r&d systems |
| 1339-ga-050 |
recombinant human galectin-7 (50 ug) |
50 ug |
r&d systems |
| 1339-ga-050/cf |
recombinant human galectin-7, cf (50 ug) |
50 ug |
r&d systems |
| 133-fb-025 |
bovine fgf basic (25 ug) |
25 ug |
r&d systems |
| 133-fb-025/cf |
bovine fgf basic, cf (25 ug) |
25 ug |
r&d systems |
| 1340-b2-050 |
recombinant rat b7-2/cd86/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1341-wf-050 |
recombinant human wif-1 (50 ug) |
50 ug |
r&d systems |
| 1341-wf-050/cf |
recombinant human wif-1, cf (50 ug) |
50 ug |
r&d systems |
| 1344-se-010 |
recombinant human kallikrein 3/psa, cf (10 ug) |
10 ug |
r&d systems |
| 1346-se-010 |
recombinant mouse granzyme g, cf (10 ug) |
10 ug |
r&d systems |
| 1357-br-050 |
recombinant mouse baff r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1360-gr-050 |
recombinant mouse growth hormone r (ghr)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1365-se-010 |
recombinant mouse granzyme d, cf (10 ug) |
10 ug |
r&d systems |
| 1366-pt-050 |
recombinant human ptp1b (aa 2-321), cf (50 ug) |
50 ug |
r&d systems |
| 136-an-050 |
recombinant mouse angiopoietin-like 3, cf (50 ug) |
50 ug |
r&d systems |
| 1375-il-025 |
recombinant human il-26/ak155 monomer (25 ug) |
25 ug |
r&d systems |
| 1375-il-025/cf |
recombinant human il-26/ak155 monomer, cf (25 ug) |
25 ug |
r&d systems |
| 1377-se-010 |
recombinant human granzyme h, cf (10 ug) |
10 ug |
r&d systems |
| 1378-rp-050 |
recombinant mouse rp105/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 137-ps-050 |
recombinant human p-selectin/cd62p/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1380-ul-050 |
recombinant human ulbp-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1384-sf-025 |
recombinant human sfrp-1 (25 ug) |
25 ug |
r&d systems |
| 1384-sf-025/cf |
recombinant human sfrp-1, cf (25 ug) |
25 ug |
r&d systems |
| 1385-rt-050 |
recombinant human relt/tnfrsf19l/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1388-nc-050 |
recombinant human n-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1389-d4-050 |
recombinant mouse dll4 (50 ug) |
50 ug |
r&d systems |
| 1389-d4-050/cf |
recombinant mouse dll4, cf (50 ug) |
50 ug |
r&d systems |
| 1390-er-050 |
recombinant mouse erythropoietin r/fc, chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1394-np-050 |
recombinant mouse nope/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1395-kc-025 |
recombinant mouse kc (aa 29-96) (25 ug) |
25 ug |
r&d systems |
| 1395-kc-025/cf |
recombinant mouse kc (aa 29-96), cf (25 ug) |
25 ug |
r&d systems |
| 1396-kn-050 |
recombinant human kininostatin (50 ug) |
50 ug |
r&d systems |
| 1396-kn-050/cf |
recombinant human kininostatin, cf (50 ug) |
50 ug |
r&d systems |
| 1397-b3-050 |
recombinant mouse b7-h3 (50 ug) |
50 ug |
r&d systems |
| 1397-b3-050/cf |
recombinant mouse b7-h3, cf (50 ug) |
50 ug |
r&d systems |
| 1398-ts-010 |
recombinant human tslp (10 ug) |
10 ug |
r&d systems |
| 1398-ts-010/cf |
recombinant human tslp, cf (10 ug) |
10 ug |
r&d systems |
| 1399-il-025 |
recombinant mouse il-17e (25 ug) |
25 ug |
r&d systems |
| 1399-il-025/cf |
recombinant mouse il-17e, cf (25 ug) |
25 ug |
r&d systems |
| 139-nk-050 |
recombinant mouse nkg2d/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1400-ir-050 |
recombinant human il-23 r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1404-tc-050 |
recombinant mouse trkc (50 ug) |
50 ug |
r&d systems |
| 1404-tc-050/cf |
recombinant mouse trkc, cf (50 ug) |
50 ug |
r&d systems |
| 1405-un-050 |
recombinant rat unc5h1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1406-st-025 |
recombinant human sost (25 ug) |
25 ug |
r&d systems |
| 1406-st-025/cf |
recombinant human sost, cf (25 ug) |
25 ug |
r&d systems |
| 1407-pi-050 |
recombinant human cystatin a, cf (50 ug) |
50 ug |
r&d systems |
| 1408-pi-050 |
recombinant human cystatin b, cf (50 ug) |
50 ug |
r&d systems |
| 1409-pi-050 |
recombinant mouse cystatin b, cf (50 ug) |
50 ug |
r&d systems |
| 140-b1-100 |
recombinant human b7-1/cd80/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1410-cr-050 |
recombinant human cryptic (50 ug) |
50 ug |
r&d systems |
| 1410-cr-050/cf |
recombinant human cryptic, cf (50 ug) |
50 ug |
r&d systems |
| 1413-fb-025 |
recombinant rat fgf-bp (25 ug) |
25 ug |
r&d systems |
| 1413-fb-025/cf |
recombinant rat fgf-bp, cf (25 ug) |
25 ug |
r&d systems |
| 141-b2-100 |
recombinant human b7-2/cd86/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1429-un-050 |
recombinant human unc5h4/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 142-dc-100 |
recombinant human dcr3/tnfrsf6b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1433-op-050 |
recombinant human osteopontin (opn) (50 ug) |
50 ug |
r&d systems |
| 1433-op-050/cf |
recombinant human osteopontin (opn), cf (50 ug) |
50 ug |
r&d systems |
| 1437-cd-050 |
recombinant mouse cd83/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 143-de-100 |
recombinant human decorin, cf (100 ug) |
100 ug |
r&d systems |
| 1440-ng-050 |
recombinant mouse nogo receptor/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1445-pl-050 |
recombinant mouse prolactin (50 ug) |
50 ug |
r&d systems |
| 1445-pl-050/cf |
recombinant mouse prolactin, cf (50 ug) |
50 ug |
r&d systems |
| 1447-pc-025 |
recombinant mouse pdgf-cc (25 ug) |
25 ug |
r&d systems |
| 1447-pc-025/cf |
recombinant mouse pdgf-cc, cf (25 ug) |
25 ug |
r&d systems |
| 144-dr-100 |
recombinant human dr6/tnfrsf21/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1454-zn-010 |
recombinant mouse kell, cf (10 ug) |
10 ug |
r&d systems |
| 1458-ht-100 |
recombinant human htra2/omi, cf (100 ug) |
100 ug |
r&d systems |
| 1459-s4-050 |
recombinant mouse igsf4, cf (50 ug) |
50 ug |
r&d systems |
| 145-cr-010 |
recombinant human cripto-1 (10 ug) |
10 ug |
r&d systems |
| 145-cr-010/cf |
recombinant human cripto-1, cf (10 ug) |
10 ug |
r&d systems |
| 1460-cd-050 |
recombinant mouse fc gamma riib/cd32b, cf (50 ug) |
50 ug |
r&d systems |
| 146-ir-100 |
recombinant human il-13 r alpha 1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1470-pi-010 |
recombinant human serpin f2/alpha 2-antiplasmin, cf (10 ug) |
10 ug |
r&d systems |
| 1473-se-010 |
recombinant human coagulation factor ii/thrombin, cf (10 ug) |
10 ug |
r&d systems |
| 1476-tr-050 |
recombinant mouse tlr1, cf |
50 µg |
r&d systems |
| 1477-ar-050 |
recombinant mouse activin rib/alk-4/fc chimera, cf |
50 µg |
r&d systems |
| 1479-tc-050 |
recombinant human tccr/wsx-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 147-ir-100 |
recombinant human il-15 r alpha/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1487-tr-050 |
recombinant human tlr3, cf (50 ug) |
50 ug |
r&d systems |
| 148-bc-100 |
recombinant human bcam/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1493-cd-050 |
recombinant human cd40/tnfrsf5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1494-tb-025 |
recombinant mouse trkb (25 ug) |
25 ug |
r&d systems |
| 1494-tb-025/cf |
recombinant mouse trkb, cf (25 ug) |
25 ug |
r&d systems |
| 1503-se-010 |
recombinant human furin, cf (10 ug) |
10 ug |
r&d systems |
| 1504-il-025 |
recombinant human il-17d (25 ug) |
25 ug |
r&d systems |
| 1504-il-025/cf |
recombinant human il-17d, cf (25 ug) |
25 ug |
r&d systems |
| 1505-lr-025 |
recombinant human lrp-6/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1506-d4-050 |
recombinant human dll4 (50 ug) |
50 ug |
r&d systems |
| 1506-d4-050/cf |
recombinant human dll4, cf (50 ug) |
50 ug |
r&d systems |
| 1507-ct-025 |
recombinant canine tnf-alpha/tnfsf1a (25 ug) |
25 ug |
r&d systems |
| 1507-ct-025/cf |
recombinant canine tnf-alpha/tnfsf2, cf (25 ug) |
25 ug |
r&d systems |
| 1508-s1-025 |
recombinant mouse soggy-1 (25 ug) |
25 ug |
r&d systems |
| 1508-s1-025/cf |
recombinant mouse soggy-1, cf (25 ug) |
25 ug |
r&d systems |
| 1513-zn-010 |
recombinant mouse ace, cf (10 ug) |
10 ug |
r&d systems |
| 1514-se-010 |
recombinant human hgf activator, cf (10 ug) |
10 ug |
r&d systems |
| 1515-cy-010 |
recombinant mouse cathepsin l, cf (10 ug) |
10 ug |
r&d systems |
| 1516-pi-050 |
recombinant mouse cystatin/stefin homolog 2, cf (50 ug) |
50 ug |
r&d systems |
| 1517-ul-050 |
recombinant human ulbp-3/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1525-dc-050 |
recombinant mouse dectin-2 alpha, cf (50 ug) |
50 ug |
r&d systems |
| 1529-tm-050 |
recombinant mouse tim-3/fc chimera, cf |
50 µg |
r&d systems |
| 1529-tm-050 |
recombinant mouse tim-3/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1530-tr-050 |
recombinant mouse tlr2, cf (50 ug) |
50 ug |
r&d systems |
| 1533-tr-050 |
recombinant mouse tlr6/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1534-ls-050 |
recombinant rat l-selectin/cd62l/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1535-lm-010 |
recombinant mouse limitin (10 ug) |
10 ug |
r&d systems |
| 1535-lm-010/cf |
recombinant mouse limitin, cf (10 ug) |
10 ug |
r&d systems |
| 1538-cr-010 |
recombinant mouse cripto (10 ug) |
10 ug |
r&d systems |
| 1538-cr-010/cf |
recombinant mouse cripto, cf (10 ug) |
10 ug |
r&d systems |
| 1539-pg-025 |
recombinant mouse gdf-8 propeptide (25 ug) |
25 ug |
r&d systems |
| 1539-pg-025/cf |
recombinant mouse gdf-8 propeptide, cf (25 ug) |
25 ug |
r&d systems |
| 1543-bp-025 |
recombinant human bmp-3b/gdf-10 (25 ug) |
25 ug |
r&d systems |
| 1543-bp-025/cf |
recombinant human bmp-3b/gdf-10, cf (25 ug) |
25 ug |
r&d systems |
| 1544-ir-050 |
recombinant human insulin r/cd220 (aa 28-956) (50 ug) |
50 ug |
r&d systems |
| 1544-ir-050/cf |
recombinant human insulin r/cd220 (aa 28-956), cf (50 ug) |
50 ug |
r&d systems |
| 1545-ra-025 |
recombinant rat il-1ra/il-1f3 (25 ug) |
25 ug |
r&d systems |
| 1545-ra-025/cf |
recombinant rat il-1ra/il-1f3, cf (25 ug) |
25 ug |
r&d systems |
| 1546-gm-025 |
recombinant canine gm-csf (25 ug) |
25 ug |
r&d systems |
| 1546-gm-025/cf |
recombinant canine gm-csf, cf (25 ug) |
25 ug |
r&d systems |
| 1548-tr-100 |
recombinant human troy/tnfrsf19/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1549-s1-025 |
recombinant human soggy-1 (25 ug) |
25 ug |
r&d systems |
| 1549-s1-025/cf |
recombinant human soggy-1, cf (25 ug) |
25 ug |
r&d systems |
| 154-al-100 |
recombinant human axl/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1559-nt-050 |
recombinant human notch-3 (aa 40-467)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1563-pi-050 |
recombinant mouse fetuin a/ahsg, cf (50 ug) |
50 ug |
r&d systems |
| 1564-lx-050 |
recombinant mouse lox-1, cf (50 ug) |
50 ug |
r&d systems |
| 1568-hp-050 |
recombinant mouse hip (50 ug) |
50 ug |
r&d systems |
| 1568-hp-050/cf |
recombinant mouse hip, cf (50 ug) |
50 ug |
r&d systems |
| 1569-pi-010 |
recombinant human kininogen hmw (hka), cf (10 ug) |
10 ug |
r&d systems |
| 156-b7-100 |
recombinant human b7-h1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1577-il-010 |
recombinant rhesus macaque il-4 (10 ug) |
10 ug |
r&d systems |
| 1577-il-010/cf |
recombinant rhesus macaque il-4, cf (10 ug) |
10 ug |
r&d systems |
| 1578-hc-025 |
recombinant human ccl14a/hcc-1 (aa 28-93) (25 ug) |
25 ug |
r&d systems |
| 1578-hc-025/cf |
recombinant human ccl14a/hcc-1 (aa 28-93), cf (25 ug) |
25 ug |
r&d systems |
| 157-er-100 |
recombinant human edar/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1580-hs-050 |
recombinant human hsp27, cf (50 ug) |
50 ug |
r&d systems |
| 1585-se-010 |
recombinant human enteropeptidase/enterokinase, cf (10 ug) |
10 ug |
r&d systems |
| 1586-hg-025 |
recombinant equine ifn-gamma (25 ug) |
25 ug |
r&d systems |
| 1586-hg-025/cf |
recombinant equine ifn-gamma, cf (25 ug) |
25 ug |
r&d systems |
| 1587-il-025 |
recombinant human il-28a/ifn-lambda 2 (25 ug) |
25 ug |
r&d systems |
| 1587-il-025/cf |
recombinant human il-28a/ifn-lambda 2, cf (25 ug) |
25 ug |
r&d systems |
| 1588-b1-025 |
recombinant mouse igfbp-1, cf (25 ug) |
25 ug |
r&d systems |
| 1589-st-025 |
recombinant mouse sost (25 ug) |
25 ug |
r&d systems |
| 1589-st-025/cf |
recombinant mouse sost, cf (25 ug) |
25 ug |
r&d systems |
| 158-b7-100 |
recombinant mouse b7-h2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1595-se-010 |
recombinant human kallikrein 11, cf (10 ug) |
10 ug |
r&d systems |
| 1596-b1-200 |
recombinant rat ephb1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 1597-fc-050 |
recombinant human fc gamma riiib/cd16b (50 ug) |
50 ug |
r&d systems |
| 1597-fc-050/cf |
recombinant human fc gamma riiib/cd16b, cf (50 ug) |
50 ug |
r&d systems |
| 1598-il-025 |
recombinant human il-29/ifn-lambda 1 (25 ug) |
25 ug |
r&d systems |
| 1598-il-025/cf |
recombinant human il-29/ifn-lambda 1, cf (25 ug) |
25 ug |
r&d systems |
| 1599-mb-050 |
recombinant human micb (aa 23-298)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 159-dp-020 |
recombinant drosophila decapentaplegic (dpp) (20 ug) |
20 ug |
r&d systems |
| 159-dp-020/cf |
recombinant drosophila decapentaplegic (dpp) , cf (20 ug) |
20 ug |
r&d systems |
| 1600-r2-050 |
recombinant mouse tgf-beta rii/(mouse) fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1603-cv-010 |
recombinant canine vegf (10 ug) |
10 ug |
r&d systems |
| 1603-cv-010/cf |
recombinant canine vegf, cf (10 ug) |
10 ug |
r&d systems |
| 1604-mk-010 |
recombinant human active mkk6, cf (10 ug) |
10 ug |
r&d systems |
| 1605-il-010 |
recombinant equine il-10 (10 ug) |
10 ug |
r&d systems |
| 1605-il-010/cf |
recombinant equine il-10, cf (10 ug) |
10 ug |
r&d systems |
| 1607-cd-050 |
recombinant human cd163, cf |
50 µg |
r&d systems |
| 1608-cl-025 |
recombinant canine cxcl8/il-8 (25 ug) |
25 ug |
r&d systems |
| 1608-cl-025/cf |
recombinant canine cxcl8/il-8, cf (25 ug) |
25 ug |
r&d systems |
| 1609-cl-025 |
recombinant canine il-6 (25 ug) |
25 ug |
r&d systems |
| 1609-cl-025/cf |
recombinant canine il-6, cf (25 ug) |
25 ug |
r&d systems |
| 1610-tw-050 |
recombinant mouse tweak r/tnfrsf12/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1613-il-020 |
recombinant equine il-2 (cys 141 ser) (20 ug) |
20 ug |
r&d systems |
| 1613-il-020/cf |
recombinant equine il-2 (cys 141 ser), cf (20 ug) |
20 ug |
r&d systems |
| 1614-fl-025 |
recombinant rat fas ligand/tnfsf6 (25 ug) |
25 ug |
r&d systems |
| 1614-fl-025/cf |
recombinant rat fas ligand/tnfsf6, cf (25 ug) |
25 ug |
r&d systems |
| 1616-rg-050 |
recombinant rat rage/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1617-fz-050 |
recombinant human frizzled-5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1618-mr-050 |
recombinant rat mis rii/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 161-dc-050 |
recombinant human dc-sign/cd209/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1627-ws-050 |
recombinant human wisp-1/ccn4, cf (50 ug) |
50 ug |
r&d systems |
| 1628-zn-020 |
recombinant e. coli methionine aminopeptidase/metap, cf (20 ug) |
20 ug |
r&d systems |
| 162-d2-050 |
recombinant human dc-signr/cd299/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1635-t2-050 |
recombinant human thrombospondin-2, cf (50 ug) |
50 ug |
r&d systems |
| 1640-nv-050 |
recombinant human nov/ccn3, cf (50 ug) |
50 ug |
r&d systems |
| 1645-zn-010 |
recombinant human ece-2, cf (10 ug) |
10 ug |
r&d systems |
| 1647-kr-025 |
recombinant mouse kremen-1 (25 ug) |
25 ug |
r&d systems |
| 1647-kr-025/cf |
recombinant mouse kremen-1, cf (25 ug) |
25 ug |
r&d systems |
| 1648-cb-050 |
recombinant human cdc25a (aa 336-524), cf (50 ug) |
50 ug |
r&d systems |
| 1649-cd-050 |
recombinant human cdc25b (aa 377-566), cf (50 ug) |
50 ug |
r&d systems |
| 1654-vh-050 |
recombinant human vhr, cf (50 ug) |
50 ug |
r&d systems |
| 165-b7-100 |
recombinant human b7-h2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1667-se-010 |
recombinant human tryptase gamma-1/tpsg1, cf (10 ug) |
10 ug |
r&d systems |
| 1668-zn-020 |
recombinant human pappalysin-2/papp-a2, cf (20 ug) |
20 ug |
r&d systems |
| 1669-pi-020 |
recombinant human serpin a4/kallistatin, cf (20 ug) |
20 ug |
r&d systems |
| 1670-se-020 |
recombinant e. coli htra/protease do, cf (20 ug) |
20 ug |
r&d systems |
| 1673-om-025 |
recombinant human omgp, cf (25 ug) |
25 ug |
r&d systems |
| 1674-mg-025 |
recombinant mouse omgp, cf (25 ug) |
25 ug |
r&d systems |
| 1680-ws-050 |
recombinant mouse wisp-1/ccn4, cf (50 ug) |
50 ug |
r&d systems |
| 1686-mr-050 |
recombinant mouse il-23 r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1687-cc-025 |
recombinant human pdgf-cc (25 ug) |
25 ug |
r&d systems |
| 1687-cc-025/cf |
recombinant human pdgf-cc, cf (25 ug) |
25 ug |
r&d systems |
| 1688-ac-025 |
recombinant human gadiponectin/gacrp30, cf (25 ug) |
25 ug |
r&d systems |
| 1689-cd-050 |
recombinant human cd58/lfa-3 (50 ug) |
50 ug |
r&d systems |
| 1689-cd-050/cf |
recombinant human cd58/lfa-3, cf (50 ug) |
50 ug |
r&d systems |
| 168-cs-100 |
recombinant mouse icos/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1690-hm-025 |
recombinant human hmgb1, cf (25 ug) |
25 ug |
r&d systems |
| 1695-cr-050 |
recombinant human crtam/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 169-cs-050 |
recombinant human icos/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1705-hh-025 |
recombinant mouse indian hedgehog (c28ii) n-terminus (25 ug) |
25 ug |
r&d systems |
| 1705-hh-025/cf |
recombinant mouse indian hedgehog (c28ii) n-terminus, cf (25 ug) |
25 ug |
r&d systems |
| 1706-sf-050 |
recombinant mouse siglec-f/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1707-cr-200 |
recombinant human c-reactive protein (200 ug) |
200 ug |
r&d systems |
| 1707-cr-200/cf |
recombinant human c-reactive protein, cf (200 ug) |
200 ug |
r&d systems |
| 1708-pi-050 |
recombinant human lipocalin-1, cf (50 ug) |
50 ug |
r&d systems |
| 1709-ml-025 |
recombinant mouse il-17b (25 ug) |
25 ug |
r&d systems |
| 1709-ml-025/cf |
recombinant mouse il-17b, cf (25 ug) |
25 ug |
r&d systems |
| 1710-pi-050 |
recombinant mouse cystatin/stefin homolog, cf (50 ug) |
50 ug |
r&d systems |
| 1714-cn-025 |
recombinant human contactin-2/tag1, cf (25 ug) |
25 ug |
r&d systems |
| 1719-se-010 |
recombinant human kallikrein 4/prostase, cf (10 ug) |
10 ug |
r&d systems |
| 1720-dm-50 |
recombinant human desmoglein-3/fc chimera, cf |
50 µg |
r&d systems |
| 1724-se-020 |
recombinant human complement masp3 catalytic domain, cf (20 ug) |
20 ug |
r&d systems |
| 1725-pi-050 |
recombinant human fetuin b, cf |
50 µg |
r&d systems |
| 1729-t2-050 |
recombinant mouse trem-2b/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1737-ms-010 |
recombinant human mis/amh (10 ug) |
10 ug |
r&d systems |
| 1737-ms-010/cf |
recombinant human mis/amh, cf (10 ug) |
10 ug |
r&d systems |
| 1744-cr-200 |
recombinant rat c-reactive protein (200 ug) |
200 ug |
r&d systems |
| 1744-cr-200/cf |
recombinant rat c-reactive protein, cf (200 ug) |
200 ug |
r&d systems |
| 1747-pi-010 |
recombinant human trappin-2/elafin, cf (10 ug) |
10 ug |
r&d systems |
| 1749-rb-050 |
recombinant rat robo1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 174-tc-050 |
recombinant human taci/tnfrsf13b/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1750-tm-050 |
recombinant human tim-1/kim-1/havcr, cf (50 ug) |
50 ug |
r&d systems |
| 1756-dc-050 |
recombinant mouse dectin-1/clec7a, cf |
50 µg |
r&d systems |
| 1756-dc-050 |
recombinant mouse dectin-1/clec7a, cf (50 ug) |
50 ug |
r&d systems |
| 1757-lc-050 |
recombinant human lipocalin-2/ngal, cf (50 ug) |
50 ug |
r&d systems |
| 175-tk-050 |
recombinant human trka/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1760-rl-010 |
recombinant rat il-12 (10 ug) |
10 ug |
r&d systems |
| 1760-rl-010/cf |
recombinant rat il-12, cf (10 ug) |
10 ug |
r&d systems |
| 1764-kr-025 |
recombinant mouse kremen-2 (25 ug) |
25 ug |
r&d systems |
| 1764-kr-025/cf |
recombinant mouse kremen-2, cf (25 ug) |
25 ug |
r&d systems |
| 1765-dk-010 |
recombinant mouse dkk-1 (10 ug) |
10 ug |
r&d systems |
| 1765-dk-010/cf |
recombinant mouse dkk-1, cf (10 ug) |
10 ug |
r&d systems |
| 176-gb-025 |
recombinant human cxcl2/gro beta (aa 39 - 107) (25 ug) |
25 ug |
r&d systems |
| 176-gb-025/cf |
recombinant human cxcl2/gro beta (aa 39 - 107), cf (25 ug) |
25 ug |
r&d systems |
| 1774-mc-025 |
recombinant canine ccl2/mcp-1 (25 ug) |
25 ug |
r&d systems |
| 1774-mc-025/cf |
recombinant canine ccl2/mcp-1, cf (25 ug) |
25 ug |
r&d systems |
| 177-ir-100 |
recombinant human il-17 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 1784-zn-010 |
recombinant human ece-1, cf (10 ug) |
10 ug |
r&d systems |
| 1785-mp-010 |
recombinant human mmp-16/mt3-mmp, cf (10 ug) |
10 ug |
r&d systems |
| 1786-pi-010 |
recombinant human serpin e1/pai-1, cf (10 ug) |
10 ug |
r&d systems |
| 1787-md-050 |
recombinant human md-2 (50 ug) |
50 ug |
r&d systems |
| 1787-md-050/cf |
recombinant human md-2, cf (50 ug) |
50 ug |
r&d systems |
| 1788-ir-050 |
recombinant human il-20 r beta/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1789-ml-025 |
recombinant mouse il-28b/ifn-lambda 3 (25 ug) |
25 ug |
r&d systems |
| 1789-ml-025/cf |
recombinant mouse il-28b/ifn-lambda 3, cf (25 ug) |
25 ug |
r&d systems |
| 1790-ca-050 |
recombinant human cadherin-11 (cad-11)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1794-lt-025 |
recombinant mouse light/tnfsf14 (25 ug) |
25 ug |
r&d systems |
| 1794-lt-025/cf |
recombinant mouse light/tnfsf14, cf (25 ug) |
25 ug |
r&d systems |
| 1795-fl-010 |
recombinant feline il-5 (10 ug) |
10 ug |
r&d systems |
| 1795-fl-010/cf |
recombinant feline il-5, cf (10 ug) |
10 ug |
r&d systems |
| 1796-fl-010 |
recombinant feline il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
| 1796-fl-010/cf |
recombinant feline il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
| 1797-ms-050 |
recombinant mouse sr-ai/msr1, cf (50 ug) |
50 ug |
r&d systems |
| 1798-lx-050 |
recombinant human lox-1, cf (50 ug) |
50 ug |
r&d systems |
| 1806-p3-010 |
recombinant human active p38 alpha, cf (10 ug) |
10 ug |
r&d systems |
| 1807-se-010 |
recombinant human complement component c1r, cf (10 ug) |
10 ug |
r&d systems |
| 1808-nr-050 |
recombinant human chordin-like 1 (50 ug) |
50 ug |
r&d systems |
| 1808-nr-050/cf |
recombinant human chordin-like 1, cf (50 ug) |
50 ug |
r&d systems |
| 1809-el-020 |
recombinant equine il-4 (20 ug) |
20 ug |
r&d systems |
| 1809-el-020/cf |
recombinant equine il-4, cf (20 ug) |
20 ug |
r&d systems |
| 1810-ec-050 |
recombinant human endocan (50 ug) |
50 ug |
r&d systems |
| 1810-ec-050/cf |
recombinant human endocan, cf (50 ug) |
50 ug |
r&d systems |
| 1814-et-025 |
recombinant equine tnf-alpha/tnfsf1a (25 ug) |
25 ug |
r&d systems |
| 1814-et-025/cf |
recombinant equine tnf-alpha/tnfsf1a, cf (25 ug) |
25 ug |
r&d systems |
| 1815-cl-020 |
recombinant canine il-2 (20 ug) |
20 ug |
r&d systems |
| 1815-cl-020/cf |
recombinant canine il-2, cf (20 ug) |
20 ug |
r&d systems |
| 1816-dt-050 |
recombinant mouse dctrail r2/tnfrsf22 (50 ug) |
50 ug |
r&d systems |
| 1816-dt-050/cf |
recombinant mouse dctrail r2/tnfrsf22, cf (50 ug) |
50 ug |
r&d systems |
| 1817-tm-050 |
recombinant mouse tim-1/kim-1/havcr (50 ug) |
50 ug |
r&d systems |
| 1817-tm-050/cf |
recombinant mouse tim-1/kim-1/havcr, cf (50 ug) |
50 ug |
r&d systems |
| 1819-kl-050 |
recombinant mouse klotho (aa 35-982), cf |
50 µg |
r&d systems |
| 1824-se-010 |
recombinant human complement factor d, cf (10 ug) |
10 ug |
r&d systems |
| 1826-ts-025 |
recombinant human pentraxin 3/tsg-14 (25 ug) |
25 ug |
r&d systems |
| 1826-ts-025/cf |
recombinant human pentraxin 3/tsg-14, cf (25 ug) |
25 ug |
r&d systems |
| 1827-sf-025 |
recombinant human sfrp-4 (25 ug) |
25 ug |
r&d systems |
| 1827-sf-025/cf |
recombinant human sfrp-4, cf (25 ug) |
25 ug |
r&d systems |
| 1829-cr-200 |
recombinant mouse c-reactive protein, cf (200 ug) |
200 ug |
r&d systems |
| 1830-sr-025 |
recombinant mouse il-6 r (aa 20-357) (25 ug) |
25 ug |
r&d systems |
| 1830-sr-025/cf |
recombinant mouse il-6 r (aa 20-357), cf (25 ug) |
25 ug |
r&d systems |
| 1836-sr-050 |
recombinant mouse signr1/cd209b/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1845-sh-025 |
recombinant human sonic hedgehog (c24ii) n-terminus (25 ug) |
25 ug |
r&d systems |
| 1845-sh-025/cf |
recombinant human sonic hedgehog (c24ii) n-terminus, cf (25 ug) |
25 ug |
r&d systems |
| 1849-nk-025 |
recombinant human nkp30/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1850-nk-025 |
recombinant human nkp46/ncr1/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 1855-cd-050 |
recombinant human cd84/slamf5 (50 ug) |
50 ug |
r&d systems |
| 1855-cd-050/cf |
recombinant human cd84/slamf5, cf (50 ug) |
50 ug |
r&d systems |
| 1857-lc-050 |
recombinant mouse lipocalin-2/ngal, cf (50 ug) |
50 ug |
r&d systems |
| 1859-dc-050 |
recombinant human dectin-1/clec7a,cf (50 ug) |
50 ug |
r&d systems |
| 185-os-025 |
recombinant human osteoprotegerin/tnfrsf11b (25 ug) |
25 ug |
r&d systems |
| 185-os-025/cf |
recombinant human osteoprotegerin/tnfrsf11b, cf (25 ug) |
25 ug |
r&d systems |
| 1865-se-010 |
recombinant mouse granzyme b, cf (10 ug) |
10 ug |
r&d systems |
| 1869-hp-025 |
recombinant human hprg, cf (25 ug) |
25 ug |
r&d systems |
| 1870-il-010 |
recombinant human il-26/ak155 dimer (10 ug) |
10 ug |
r&d systems |
| 1870-il-010/cf |
recombinant human il-26/ak155 dimer, cf (10 ug) |
10 ug |
r&d systems |
| 1875-cd-050 |
recombinant human fc gamma riib/c (cd32b/c), cf (50 ug) |
50 ug |
r&d systems |
| 1878-sh-010 |
recombinant human active shp-1 (aa 205-595), cf |
10 µg |
r&d systems |
| 1886-el-025 |
recombinant equine il-6 (25 ug) |
25 ug |
r&d systems |
| 1886-el-025/cf |
recombinant equine il-6, cf (25 ug) |
25 ug |
r&d systems |
| 1887-ml-010 |
recombinant mouse il-23 (10 ug) |
10 ug |
r&d systems |
| 1887-ml-010/cf |
recombinant mouse il-23, cf (10 ug) |
10 ug |
r&d systems |
| 1888-lm-050 |
recombinant mouse limpii/sr-b2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1889-pi-010 |
recombinant human cystatin f, cf (10 ug) |
10 ug |
r&d systems |
| 188-c8-005 |
recombinant human cadherin-8 (cad-8)/fc chimera, cf (5 ug) |
5 ug |
r&d systems |
| 1890-fl-020 |
recombinant feline il-2 (20 ug) |
20 ug |
r&d systems |
| 1890-fl-020/cf |
recombinant feline il-2, cf (20 ug) |
20 ug |
r&d systems |
| 1894-sh-100 |
recombinant human active shp-2, cf |
100 µg |
r&d systems |
| 1894-sh-100 |
recombinant human active shp-2, cf |
100 µg |
r&d systems |
| 1895-sa-050 |
recombinant rat pentraxin 2/sap (50 ug) |
50 ug |
r&d systems |
| 1895-sa-050/cf |
recombinant rat pentraxin 2/sap, cf (50 ug) |
50 ug |
r&d systems |
| 1896-tl-010 |
recombinant mouse tl1a/tnfsf15 (10 ug) |
10 ug |
r&d systems |
| 1896-tl-010/cf |
recombinant mouse tl1a/tnfsf15, cf (10 ug) |
10 ug |
r&d systems |
| 1898-cd-050 |
recombinant human cd229/slamf3, cf |
50 µg |
r&d systems |
| 1905-hp-025 |
recombinant mouse hprg, cf (25 ug) |
25 ug |
r&d systems |
| 1907-bl-050 |
recombinant human blame/slamf8, cf |
50 µg |
r&d systems |
| 1907-bl-050 |
recombinant human blame/slamf8, cf |
50 µg |
r&d systems |
| 1908-nt-050 |
recombinant human ntb-a/slamf6/fc chimera, cf |
50 µg |
r&d systems |
| 1915-mf-050 |
recombinant human mfrp, cf (50 ug) |
50 ug |
r&d systems |
| 1918-fn-02m |
human fibronectin, cf (2 mg) |
2 mg |
r&d systems |
| 191-ed-010 |
recombinant mouse ectodysplasin (eda) (10 ug) |
10 ug |
r&d systems |
| 191-ed-010/cf |
recombinant mouse ectodysplasin (eda), cf (10 ug) |
10 ug |
r&d systems |
| 1920-sp-050 |
recombinant human sp-d, cf |
50 µg |
r&d systems |
| 1920-sp-050 |
recombinant human sp-d, cf |
50 µg |
r&d systems |
| 1927-zn-010 |
recombinant human bmp-1/pcp, cf (10 ug) |
10 ug |
r&d systems |
| 1928-se-010 |
recombinant mouse spinesin, cf (10 ug) |
10 ug |
r&d systems |
| 192-sf-010 |
recombinant human sfrp-3 (10 ug) |
10 ug |
r&d systems |
| 192-sf-010/cf |
recombinant human sfrp-3, cf (10 ug) |
10 ug |
r&d systems |
| 1930-pt-050 |
recombinant human tc-ptp (aa 2-314), cf (50 ug) |
50 ug |
r&d systems |
| 1934-dp-010 |
recombinant human dep-1/cd148 (aa 997-1337), cf (10 ug) |
10 ug |
r&d systems |
| 1936-se-010 |
recombinant human complement component c2, cf (10 ug) |
10 ug |
r&d systems |
| 1937-se-010 |
recombinant mouse tryptase beta-1/mcpt-7, cf (10 ug) |
10 ug |
r&d systems |
| 1938-pi-050 |
human alpha-2-macroglobulin, cf (50 ug) |
50 ug |
r&d systems |
| 1939-se-200 |
human plasminogen, cf (200 ug) |
200 ug |
r&d systems |
| 193-bc-050 |
recombinant human bcma/tnfrsf17/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1945-rl-025 |
recombinant rat il-13 (25 ug) |
25 ug |
r&d systems |
| 1945-rl-025/cf |
recombinant rat il-13, cf (25 ug) |
25 ug |
r&d systems |
| 1946-kr-025 |
recombinant human kremen-2 (25 ug) |
25 ug |
r&d systems |
| 1946-kr-025/cf |
recombinant human kremen-2, cf (25 ug) |
25 ug |
r&d systems |
| 1947-ms-050 |
recombinant human msp r/ron, cf (50 ug) |
50 ug |
r&d systems |
| 1948-sa-050 |
recombinant human pentraxin 2/sap (50 ug) |
50 ug |
r&d systems |
| 1948-sa-050/cf |
recombinant human pentraxin 2/sap, cf (50 ug) |
50 ug |
r&d systems |
| 1949-b3-050 |
recombinant human b7-h3 (50 ug) |
50 ug |
r&d systems |
| 1949-b3-050/cf |
recombinant human b7-h3, cf (50 ug) |
50 ug |
r&d systems |
| 194-fz-050 |
recombinant mouse frizzled-4/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1950-m5-050 |
recombinant human icam-5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1954-fl-025 |
recombinant feline il-12 (25 ug) |
25 ug |
r&d systems |
| 1954-fl-025/cf |
recombinant feline il-12, cf (25 ug) |
25 ug |
r&d systems |
| 1955-cd-050 |
recombinant human cd36/sr-b3/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1956-cv-050 |
recombinant human crossveinless-2 (50 ug) |
50 ug |
r&d systems |
| 1956-cv-050/cf |
recombinant human crossveinless-2, cf (50 ug) |
50 ug |
r&d systems |
| 1957-kg-025 |
recombinant canine kgf/fgf-7 (25 ug) |
25 ug |
r&d systems |
| 1957-kg-025/cf |
recombinant canine kgf/fgf-7, cf (25 ug) |
25 ug |
r&d systems |
| 1958-gd-010 |
recombinant human gdf-11/bmp-11 (10 ug) |
10 ug |
r&d systems |
| 1958-gd-010/cf |
recombinant human gdf-11/bmp-11, cf (10 ug) |
10 ug |
r&d systems |
| 1959-b2-050 |
recombinant human il-12 r beta 2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1960-fc-050 |
recombinant mouse fc gamma riii/cd16, cf (50 ug) |
50 ug |
r&d systems |
| 1964-cl-025 |
recombinant canine il-5 (25 ug) |
25 ug |
r&d systems |
| 1964-cl-025/cf |
recombinant canine il-5, cf (25 ug) |
25 ug |
r&d systems |
| 1965-il-025 |
recombinant human il-24 (25 ug) |
25 ug |
r&d systems |
| 1965-il-025/cf |
recombinant human il-24, cf (25 ug) |
25 ug |
r&d systems |
| 1966-lm-050 |
recombinant human limpii/sr-b2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1967-ng-025/cf |
recombinant mouse noggin, cf (25 ug) |
25 ug |
r&d systems |
| 1968-sl-050 |
recombinant human siglec-2/cd22/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1969-cl-025 |
recombinant canine il-12/il-23 p40 (25 ug) |
25 ug |
r&d systems |
| 1969-cl-025/cf |
recombinant canine il-12/il-23 p40, cf (25 ug) |
25 ug |
r&d systems |
| 1970-tx-500 |
recombinant human thioredoxin-1, cf (500 ug) |
500 ug |
r&d systems |
| 1974-cd-050 |
recombinant mouse fcrl3/cd16-2, cf (50 ug) |
50 ug |
r&d systems |
| 1975-il-025 |
recombinant human il-1f7/fil1 zeta, cf (25 ug) |
25 ug |
r&d systems |
| 1976-nv-050 |
recombinant mouse nov/ccn3, cf (50 ug) |
50 ug |
r&d systems |
| 1977-mr-050 |
recombinant human il-11 r alpha/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1978-mf-025 |
recombinant mouse mif (25 ug) |
25 ug |
r&d systems |
| 1978-mf-025/cf |
recombinant mouse mif, cf (25 ug) |
25 ug |
r&d systems |
| 1988-se-010 |
recombinant human marapsin/pancreasin, cf (10 ug) |
10 ug |
r&d systems |
| 1989-se-010 |
recombinant mouse marapsin/pancreasin, cf (10 ug) |
10 ug |
r&d systems |
| 198-fz-050 |
recombinant mouse frizzled-7/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 1998-b1-050 |
recombinant mouse il-12 r beta 1, cf (50 ug) |
50 ug |
r&d systems |
| 1999-ec-050 |
recombinant mouse endocan, cf |
50 µg |
r&d systems |
| 2009-cd-050 |
recombinant human cd55/daf (50 ug) |
50 ug |
r&d systems |
| 2009-cd-050/cf |
recombinant human cd55/daf, cf (50 ug) |
50 ug |
r&d systems |
| 200-la-002 |
recombinant human il-1 alpha/il-1f1 (2 ug) |
2 ug |
r&d systems |
| 200-la-002/cf |
recombinant human il-1 alpha/il-1f1, cf (2 ug) |
2 ug |
r&d systems |
| 200-la-010 |
recombinant human il-1 alpha/il-1f1 (10 ug) |
10 ug |
r&d systems |
| 200-la-010/cf |
recombinant human il-1 alpha/il-1f1, cf (10 ug) |
10 ug |
r&d systems |
| 2017-t2-050 |
recombinant human ilt2/cd85/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 201-lb-005 |
recombinant human il-1 beta/il-1f2 (5 ug) |
5 ug |
r&d systems |
| 201-lb-005/cf |
recombinant human il-1 beta/il-1f2, cf (5 ug) |
5 ug |
r&d systems |
| 201-lb-025 |
recombinant human il-1 beta/il-1f2 (25 ug) |
25 ug |
r&d systems |
| 201-lb-025/cf |
recombinant human il-1 beta/il-1f2, cf (25 ug) |
25 ug |
r&d systems |
| 2025-se-010 |
recombinant human kallikrein 8/neuropsin, cf (10 ug) |
10 ug |
r&d systems |
| 2026-em-050 |
recombinant mouse pro-emap-ii, cf |
50 µg |
r&d systems |
| 2026-em-050 |
recombinant mouse pro-emap-ii, cf |
50 µg |
r&d systems |
| 2028-eg-200 |
recombinant mouse egf, cf (200 ug) |
200 ug |
r&d systems |
| 202-il-010/cf |
recombinant human il-2, cf (10 ug) |
10 ug |
r&d systems |
| 202-il-050/cf |
recombinant human il-2, cf (50 ug) |
50 ug |
r&d systems |
| 2034-nr-050 |
recombinant human nrcam/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 2036-bc-050 |
recombinant human boc, cf |
50 µg |
r&d systems |
| 2037-c5-025 |
recombinant human complement component c5a (25 ug) |
25 ug |
r&d systems |
| r&d systems 产品目录列表 page 2 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
400 8700 545
400 8700 545
